EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of the efficacy of a live attenuated vaccine (porcimune PRRS MLV) against porcine reproductive and respiratory syndrome virus in landrace piglets

Carlos A García-Munguía iD, María R Robles-López iD, Dhamar A Ramírez-Castillo iD, Raúl R Robles-de la Torre iD, Gloria P Galaviz-Martínez iD, José N Aguilar-Toribio iD, Alejandro Flores-Montenegro iD, Pablo Pineyro iD, Fabián Correa-Morales iD, Otilio García-Munguía iD, Miguel Ángel Plascencia-Espinosa iD, Alberto M García-Munguía iD

Translational Animal Science · 15.01.2026 · 10

DOI: 10.1093/tas/txag176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Animal Science, online erschienen am 28.10.2026. Verfasst von Carlos A García-Munguía und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Veterinaria y Zootecnia, Universidad de Guanajuato (UG), Guanajuato, 36500, Mexico. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lapisa S.A. de C.V..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine reproductive and respiratory syndrome virus (PRRSV) represents a constant challenge for the swine industry, both in Mexico and internationally, due to its high genetic variability and immunosuppressive capacity. This study evaluated the comparative efficacy of four modified-live vaccines in 3 to 4-wk-old seronegative piglets challenged intramuscularly with the heterologous PRRSV strain DAP150520 at 35 d post-vaccination (dpv; 0 d post-challenge, dpc). Fifty piglets were randomly allocated into five groups (n = 10/group): G1, ATCC-VR-2332; G2, SJO151012 ≥ 104 (Porcimune); G3, P129; G4, attenuated Nebraska ≥ 4.0; and G5, unvaccinated controls. Outcomes included ELISA seroconversion, qRT-PCR cycle threshold (Ct) values (PRRSV RNA detection), daily clinical scoring, BW, and gross lung lesions assessed using the modified Madec scale at 7 dpc. Group 2 (Porcimune) showed complete seroconversion from 21 dpv, controlled post-challenge viremia (cycle threshold [Ct] = 21.84 at 7 dpc), and a 57% reduction in lung lesions compared with controls. Group 1 (ATCC-VR-2332) also reached complete seroconversion by 21 dpv, whereas Group 3 (P129) showed early but fluctuating seroconversion and Group 4 (attenuated Nebraska) showed delayed and inconsistent seroconversion across sampling points, and Group 5 (control) remained seronegative until after challenge. Group 3 achieved a 63% reduction in lung damage, although with a more variable immune response. In contrast, G1, G4, and the control group showed lung lesions in 100% of animals after challenge. Post-challenge BW gain was significantly greater in G1 and G2 than in the unvaccinated control (one-way ANOVA, P = 0.023; Tukey’s HSD, P = 0.039 and P = 0.045, respectively), meanwhile the control group showed a net BW loss after challenge. Overall, under these experimental conditions, Porcimune PRRS MLV was the only vaccine that differed significantly from unvaccinated controls in lung lesions, post-challenge BW gain and ELISA S/P ratio, supporting its protective potential against a heterologous PRRSV challenge.

Schlagwörter

Stichwörter der Autor:innen

challengeefficacyimmunogenicitylung lesionporcine reproductive and respiratory syndrome virusvaccine

Autor:innen und Institutionen

  • Departamento de Veterinaria y Zootecnia, Universidad de Guanajuato (UG), Guanajuato, 36500, Mexico.
  • Centro de Investigación en Biotecnología Aplicada (CIBA), Instituto Politécnico Nacional (IPN), Tlaxcala, 90700, Mexico.
  • Departamento de Investigación y Desarrollo, Lapisa, La Piedad, Michoacán, 59375, Mexico.
  • Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, United States.
  • Centro Nacional de Prevención y Control de Enfermedades (CENAPRECE), Secretaría de Salud México, Mexico City, 11800, Mexico.
  • Centro de Ciencias Agropecuarias, Universidad Autónoma de Aguascalientes (UA), Aguascalientes, 20131, Mexico.

ORCID-Profile: Carlos A García-Munguía, María R Robles-López, Dhamar A Ramírez-Castillo, Raúl R Robles-de la Torre, Gloria P Galaviz-Martínez, José N Aguilar-Toribio, Alejandro Flores-Montenegro, Pablo Pineyro, Fabián Correa-Morales, Otilio García-Munguía, Miguel Ángel Plascencia-Espinosa, Alberto M García-Munguía

Förderung

  • Lapisa S.A. de C.V.

Zitieren

APA

García-Munguía, C. A., Robles-López, M. R., Ramírez-Castillo, D. A., Robles-de la Torre, R. R., Galaviz-Martínez, G. P., Aguilar-Toribio, J. N., Flores-Montenegro, A., Pineyro, P., Correa-Morales, F., García-Munguía, O., Plascencia-Espinosa, M. Á., & García-Munguía, A. M. (2026). Evaluation of the efficacy of a live attenuated vaccine (porcimune PRRS MLV) against porcine reproductive and respiratory syndrome virus in landrace piglets. Translational Animal Science, 10. https://doi.org/10.1093/tas/txag176

Vancouver

García-Munguía CA, Robles-López MR, Ramírez-Castillo DA, Robles-de la Torre RR, Galaviz-Martínez GP, Aguilar-Toribio JN, et al. Evaluation of the efficacy of a live attenuated vaccine (porcimune PRRS MLV) against porcine reproductive and respiratory syndrome virus in landrace piglets. Translational Animal Science. 2026;10. doi:10.1093/tas/txag176

BibTeX
@article{GarcaMungua2026,
  author = {García-Munguía, Carlos A and Robles-López, María R and Ramírez-Castillo, Dhamar A and Robles-de la Torre, Raúl R and Galaviz-Martínez, Gloria P and Aguilar-Toribio, José N and Flores-Montenegro, Alejandro and Pineyro, Pablo and Correa-Morales, Fabián and García-Munguía, Otilio and Plascencia-Espinosa, Miguel Ángel and García-Munguía, Alberto M},
  title = {Evaluation of the efficacy of a live attenuated vaccine (porcimune PRRS MLV) against porcine reproductive and respiratory syndrome virus in landrace piglets},
  journal = {Translational Animal Science},
  year = {2026},
  volume = {10},
  doi = {10.1093/tas/txag176}
}
Kostenlos starten →